Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Influenza Humans (20)
- Medical Specialties (20)
- Medical Sciences (13)
- COVID-19 (10)
- Pediatrics (10)
-
- Diseases (9)
- Life Sciences (8)
- Infectious Disease (7)
- Epidemiology (6)
- Social and Behavioral Sciences (6)
- Virus Diseases (6)
- Clinical Epidemiology (5)
- Immunology and Infectious Disease (5)
- International Public Health (5)
- Law (5)
- Bioethics and Medical Ethics (4)
- Immune System Diseases (4)
- Community Health and Preventive Medicine (3)
- Health Policy (3)
- Immunology of Infectious Disease (3)
- Intellectual Property Law (3)
- Mental and Social Health (3)
- Microbiology (3)
- Public Affairs, Public Policy and Public Administration (3)
- Public Health Education and Promotion (3)
- Sociology (3)
- Tropical Medicine (3)
- Institution
- Publication Year
- Publication
-
- Faculty, Staff and Students Publications (10)
- Center for Medical Ethics and Health Policy Staff Publications (3)
- Department of Paediatrics and Child Health (3)
- Faculty, Staff and Student Publications (3)
- All Faculty Scholarship (2)
-
- International Undergraduate Journal of Health Sciences (2)
- Law Faculty Scholarship (2)
- Dartmouth Scholarship (1)
- Graduate Student Theses, Dissertations, & Professional Papers (1)
- Honors Scholar Theses (1)
- IGHD Newsletters Archives (1)
- Journal of Health Ethics (1)
- Manuscripts, Articles, Book Chapters and Other Papers (1)
- Medical Student Research Symposium (1)
- Nevada Journal of Public Health (1)
- Pharmacy Faculty Articles and Research (1)
- Publication Type
Articles 31 - 34 of 34
Full-Text Articles in Influenza Virus Vaccines
B Cell Response And Hemagglutinin Stalk-Reactive Antibody Production In Different Age Cohorts Following 2009 H1n1 Influenza Virus Vaccination, Mark Y. Sangster, Jane Baer, Felix W. Santiago, Theresa T. Fitzgerald, Natalia A. Ilyushina
B Cell Response And Hemagglutinin Stalk-Reactive Antibody Production In Different Age Cohorts Following 2009 H1n1 Influenza Virus Vaccination, Mark Y. Sangster, Jane Baer, Felix W. Santiago, Theresa T. Fitzgerald, Natalia A. Ilyushina
Dartmouth Scholarship
The 2009 pandemic H1N1 (pH1N1) influenza virus carried a swine-origin hemagglutinin (HA) that was closely related to the HAs of pre-1947 H1N1 viruses but highly divergent from the HAs of recently circulating H1N1 strains. Consequently, prior ex- posure to pH1N1-like viruses was mostly limited to individuals over the age of about 60 years. We related age and associated dif- ferences in immune history to the B cell response to an inactivated monovalent pH1N1 vaccine given intramuscularly to subjects in three age cohorts: 18 to 32 years, 60 to 69 years, and >70 years. The day 0 pH1N1-specific hemagglutination inhibition (HAI) …
In Vitro Characterization Of Avian Influenza Virus Isolates With A Truncated Ns1 Gene Segment, Aaron Dick
In Vitro Characterization Of Avian Influenza Virus Isolates With A Truncated Ns1 Gene Segment, Aaron Dick
Honors Scholar Theses
Avian Influenza Virus represents a significant threat to the world poultry population, and is a potential threat to humans due to the possibility of cross-species AIV infection. Our approach is to characterize a number of avian virus populations with respect to their content of biologically active particles that include hemagglutinating particles (HAP), plaque forming particles (PFP), interferon inducing particles (IFP), interferon induction-suppressing particles (ISP), defective-interfering particles (DIP), cell-killing particles (CKP) and non-infectious cell killing particles (niCKP) using unique in vitro assays developed for avian influenza virus in the Marcus-Sekellick Laboratory. Specifically, we will use a strain of Avian influenza virus, …
Intellectual Property Management Strategies To Accelerate The Development And Access Of Vaccines And Diagnostics: Case Studies On Pandemic Influenza, Malaria And Sars, Anatole Krattiger, Stanley P. Kowalski, Robert Eiss, Anthony Taubman
Intellectual Property Management Strategies To Accelerate The Development And Access Of Vaccines And Diagnostics: Case Studies On Pandemic Influenza, Malaria And Sars, Anatole Krattiger, Stanley P. Kowalski, Robert Eiss, Anthony Taubman
Law Faculty Scholarship
Achieving global access to vaccines, diagnostics, and pharmaceuticals remains a challenge. Throughout the developing world, intellectual property (IP) constraints complicate access to critically essential medical technologies and products. Vaccines for malaria and pandemic strains of influenza, as well as diagnostic and vaccine technologies for SARS, are not only relevant to global public health but are particularly critical to the needs of developing countries. A global access solution is urgently needed. This article offers a timely case‐by‐case analysis of preliminary patent landscape surveys and formulates options via patent pools and other forms of creative IP management to accelerate development and access. …
Pierce Law Participates In Pandemic Influenza Vaccine Ip Management Meeting, Stanley P. Kowalski
Pierce Law Participates In Pandemic Influenza Vaccine Ip Management Meeting, Stanley P. Kowalski
Law Faculty Scholarship
On April 18, 2006 several members of the greater Pierce Law community participated in an important meeting held at the World Intellectual Property Organization (WIPO) in Geneva, Switzerland. Organized by The Centre for the Management of Intellectual Property in Health Research and Development (MIHR), the meeting “Intellectual Property Management Strategies to Facilitate Early Access and Global Health Benefits: Case Studies in Pandemic Influenza and Malaria” had the objective of exploring and discussing IP issues which impact the distribution of vaccines to developing countries, a topic of heightened worldwide importance given the potential threat of a global influenza pandemic. In an …